Relationship between metabolic syndrome and female sexual dysfunction

Year 2014, , 269 - 273, 01.09.2014

Rıfkı Üçler Eda Demir Önal Celil Alper Usluoğulları Cafer Kaya Sedat Caner Abbas Ali Tam Betül Usluoğulları Hasan Tunca Engin Sennaroğlu

https://doi.org/10.5505/abantmedj.2014.41736

Abstract

Objective: The aim of our study is to assess the degree of sexual dysfunction in the sexually active women diagnosed with the metabolic syndrome MS and to investigate the relationship between sexual function and metabolic syndrome. Method: Fifty-six women were included in this study. The patient group was composed of 37 patients meeting NCEPATP III criteria for MS whereas the control group involved 19 healthy women. The parciticipants' sexual fuction was assessed by “Index of Female Sexual Function” IFSF . Results: The mean age of the patients with MS was 38.38±9.6 years, whereas that of the control group was 35.95±7.64 years, with no statistically significant difference between the two groups. The IFSF score was 26.4±4.4 in the patient group and 27.5±5.2 in control group. There was no statistically significant difference between the two groups regarding IFSF score. In the control group there is negative correlation between the IFSF score and the diastolic blood pressure r =0.460, p

Keywords

Metabolic syndrome, female sexual dysfunction.

Metabolik sendrom ve kadın cinsel fonksiyon bozukluğu arasındaki ilişki

Abstract

Amaç: Çalışmamızın amacı, metabolik sendrom MS tanısı konan seksüel aktif kadınlarda cinsel fonksiyon bozukluğu CFB derecesini sağlıklı kadınlarla karşılaştırarak, kadın cinsel fonksiyon düzeyi ve MS arasındaki ilişkiyi araştırmaktır. Yöntem: Çalışmaya toplam 56 kadın hasta alındı. NCEP ATP III tanı kriterlerine göre MS tanısı konulan 37 hasta vaka grubu olarak, MS olmayan 19 hasta ise kontrol grubu olarak alındı. Cinsel işlev sorgulanmasında, Kadın Cinsel Fonksiyon Sorgulama İndeksi IFSF kullanıldı. Bulgular: Yaş ortalaması vaka grubunda 38.38±9.6, kontrol grubunda ise 35.95±7.64 olarak saptandı. Vaka ve kontrol grupları arasında yaş ortalamaları açısından istatistiksel anlamlı farklılık yoktu. Vaka grubunda IFSF skoru ortalaması 26.4±4.4, kontrol grubunda ise 27.5±5.2 olarak bulundu. Vaka ve kontrol grupları arasında IFSF skorları açısından istatistiksel anlamlı farklılık saptanmadı. Kontrol grubunda IFSF skoru ile diyastolik kan basıncı arasında orta düzeyde negatif korelasyon saptandı r =0.460, p

Keywords

Metabolik sendrom, kadın cinsel fonksiyon bozukluğu.

References

• 1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287(3):356–359.
• 2. Kozan O, Oguz A, Abaci A, Erol C, Ongen Z, Temizhan A, Celik S. Prevalence of the metabolic syndrome among Turkish adults. Eur J Clin Nutr 2007; 61(4):548-553.
• 3. Geiss IM, Umek WH, Dungl A, Sam C, Riss P, Hanzal E. Prevalence of female sexual dysfunction in gynecologic and urogynecologic patients according to the international consensus classification. Urology 2003; 62(3):514–518.
• 4. Corona G, Mannucci E, Schulman C, Petrone L, Mansani R, Cilotti A, Balercia G, Chiarini V, Forti G, Maggi M. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol 2006; 50(3):595–604.
• 5. Kaplan SA, Meehan AG, Shah A. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol 2006; 176:1524–1527.
• 6. Ayhan K, Mehmet Bilgehan Y. Santral obezite göstergesi olan bel çevresinin alt üriner sistem semptomları, erektil disfonksiyon ve metabolik sendrom komponentleri ile ilişkisi. Dicle Med J 2012; 39 (4):504-508.
• 7. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281(6):537–544.
• 8. Berman JR, Goldstein I. Female sexual dysfunction. Urol Clin North Am 2001; 28(2):405– 416.
• 9. Leiblum S, Bachmann G, Kemmann E, Colburn D, Swartzman L. Vaginal atrophy in the postmenopausal woman: the importance of sexual activity and hormones. JAMA 1983; 249(16):2195– 2198.
• 10. Kirchengast S, Hartmann B, Gruber D, Huber J. Decreased sexual interest and its relationship to body build in postmenopausal women. Maturitas 1996; 23(1):63–71.
• 11. Brody S. Slimness is associated with greater intercourse and lesser masturbation frequency. J Sex Marital Ther 2004; 30(4):251–261.
• 12. Kinzl JF, Trefalt E, Fiala M, Hotter A, Biebl W, Aigner F. Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding. Obes Surg 2001; 11(4):455–458.
• 13. Esposito K, Ciotola M, Marfella R, Di Tommaso D, Cobellis L, Giugliano D. The metabolic syndrome: a cause of sexual dysfunction in women. Int J Impot Res 2005; 17(3):224–226.
• 14. Burchardt M, Burchardt T, Anastasiadis AG, Kiss AJ, Baer L, Pawar RV, de la Taille A, Shabsigh A, Ghafar MA, Shabsigh R. Sexual dysfunction is common and overlooked in female patients with hypertension. J Sex Marital Ther 2002; 28(1):17–26.
• 15. Erol B, Tefekli A, Sanli O, Ziylan O, Armagan A, Kendirci M, Eryasar B, Kadıoğlu A. Does sexual dysfunction correlate with deterioration of somatic sensory system in diabetic women? Int J Impot Res 2003; 15(3):198-202.
• 16. Esposito K, Ciotola M, Giugliano F, Bisogni C, Schisano B, Autorino R, Cobellis L, De Sio M, Colacurci N, Giugliano D. Association of body weight with sexual function in women. Int J Impot Res 2007; 19(4):353-357.
• 17. Corona G, Mannucci E, Petrone L, Schulman C, Balercia G, Fisher AD, Chiarini V, Forti G, Maggi M. A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction. J Sex Med 2007 ;4(3):789-796.